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Abstract: A proof of concept for a one-pot process merging a heterocycle formation by a classical
chemical approach at basic conditions with a biocatalytic reduction, running at neutral pH conditions,
is reported. A crucial component for this process is the compartmentalization of the single reactions
by the use of polydimethylsiloxane thimbles. This process was applied successfully towards
an asymmetric synthesis of (S)-2,2,3-trimethyl-1-thia-4-azaspiro[4.4]nonane, leading to excellent
enantioselectivities of 99% enantiomeric excess (ee).
Keywords: Asinger-type multi-component reaction; asymmetric synthesis; biocatalysis; cascades;
compartmentalization; heterocycles
1. Introduction
The development of chemoenzymatic one-pot processes for particularly industrially relevant
compound classes by combining biotransformations with chemocatalytic or other chemical reactions has
recently gained increasing interest since intermediate isolations can be avoided, thus offering an option
for a higher resource efficiency of such multi-step syntheses by minimizing solvent consumption and
overall waste formation [1]. It is noteworthy that engineering of such processes has also been achieved
for combining enzyme catalysis and chemocatalytic reactions, being not compatible with each other [2].
Successful engineering concepts for merging non-compatible catalytic systems with each other include,
for example, biphasic systems [3,4], supramolecular hosts [5], artificial metalloenzymes [6–8], or spatial
separation by flow chemistry [4,9]. Recently, the separation of the biocatalytic from the chemocatalytic
reaction by means of polydimethylsiloxane (PDMS)-thimbles turned out as another suitable strategy
for this purpose. Originally pioneered by the Bowden group [10–12] for merging chemocatalytic and
“classic” chemical reactions, the Gröger group demonstrated the usefulness of this concept also for
combining non-compatible chemo- and biocatalytic transformations, exemplified for the combination
of a Wacker-oxidation with an enzymatic reduction [13]. In the meantime, this methodology was
applied to a range of other combinations of metal-catalyzed transformations (Suzuki reactions, Wacker
oxidations) and biotransformations (e.g., halogenases, transaminases, amine dehydrogenases) [14–16].
In continuation with our recent studies on the chemoenzymatic enantioselective synthesis of sulfur-
containing heterocyclic amines consisting of an initial formation of heterocyclic imines and subsequent
enzymatic reduction [17], we became interested to combine these reactions within a one-pot cascade process.
As the “process windows“ for these two reactions differ strongly from each other (e.g., in terms of required
pH conditions), we envisioned that the compartmentalization concept using PDMS thimbles applied
already successfully for a range of combinations of chemo- and biocatalytic transformations [10–16] might
be an option for such a combination of heterocyclic chemistry and biocatalysis. In the following, we report
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our results in this field demonstrating a proof of concept for such an engineered process, which to the
best of our knowledge represents the first example of a one-pot process merging a heterocycle formation
through a classic chemical process at strongly basic conditions with a biocatalytic reaction running at
neutral pH conditions. This process concept, which was successfully applied towards an asymmetric
one-pot synthesis of (S)-2,2,3-trimethyl-1-thia-4-azaspiro[4.4]nonane (4a), also opens up an option for
combining further reactions in the field of formation of heterocycles with enzymatic reactions towards
one-pot processes running in water.
2. Materials and Methods
2.1. Preparation of the PDMS Thimbles for Compartmentalization of the Reaction Steps
The PDMS thimbles were prepared according to Uthoff et al. [14]. The surface of a glass vial
(1.5 mL) is passivated by addition of a few drops of trichloro-(1H, 1H, 2H, 2H-perfluoroctyl)silane
onto the glass vial and incubation in a desiccator at 45 mbar over night. Sylgard® 184 (Sigma-Aldrich,
St. Louis, MO, USA) is mixed, degassed, and heated to 65 ◦C for 5 min. The glass vial is dipped into
the solution of Sylgard® 184 until no formation of new drops is observed and incubated upside down
at 65 ◦C for 1 h. This step is repeated twice. In the third round the glass vial is incubated upright for
1 h at 120 ◦C to cure the PDMS. For release of the PDMS thimble from the glass vial, the glass vial is
incubated in n-hexane. The PDMS thimble is washed with dichloromethane and water and afterwards
used for reactions.
2.2. Construction and Expression of Whole-Cell Catalyst
The imine reductase [18], as well as the glucose dehydrogenase, used in this work are literature-
known enzymes. Escherichia coli strain BL21(DE3), which was used for expression, and pACYCDuet-1
vector were purchased from Novagen (Madison, WI, USA). The whole-cell catalyst was constructed as
a two-plasmid-system, harbouring the gene for the glucose dehydrogenase from Bacillus subtilis in
a pACYCDuet-1 vector [17,19,20], and the gene for the imine reductase from Mycobacterium smegmatis
in the commercially available pET-22b(+) vector [18]. A preculture of E. coli BL21(DE3) carrying
the two recombinant plasmids was cultivated over-night at 37 ◦C in 10 mL LB medium, containing
80 µg·mL−1 of carbenicillin and 28 µg·mL−1 of chloramphenicol. The main culture containing 600 mL
TB medium, 80 µg·mL−1 of carbenicillin, and 28 µg·mL−1 of chloramphenicol, was inoculated with
the starting culture to a final concentration of 1%. At an OD600 between 0.4 and 0.6, the production
of recombinant protein was induced by addition of isopropyl-thio-β-D-galactoside (IPTG) to a final
concentration of 0.5 mM. Cultures were shaken at 25 ◦C for 20 h and cells harvested by centrifugation
(4000 g, 30 min, 4 ◦C). For lyophilization of the cells, a 50% cell suspension in water was used and the
resulting lyophilized cells were stored in a freezer at −20 ◦C.
2.3. GC Analytics for the Determination of the Conversion
Conversions for the biotransformations of 3-thiazoline (3a) to the corresponding 3-thiazolidine
(4a) and overall conversions for the synthesis of 4a as well as amount of diffusion of 3a through the
PDMS membrane were determined by means of gaschromatography. Analysis was carried out using
the gaschromatograph system GC-2010 Plus (Shimadzu, Kyoto, Japan) equipped with ZB-5MSi column
(Phenomenex, Torrance, CA, USA, 30 m × 0.25 mm × 0.25 µm; N2; linear velocity 46.9 cm·s−1 split
mode 1:10; total flow 28.8 mL·min−1; purge flow 3.0 mL·min−1; column flow 2.34 mL·min−1; pressure
140.4 kPa) and coupled to an AOC-20i/s auto injector/auto sampler.
Temperature program: 40 ◦C–200 ◦C, 10 ◦C·min−1.
Retention time for 2,2,3-trimethyl-1-thia-4-azaspiro[4.4]non-3-ene (3a): 8.52 min.
Retention time for 2,2,3-Trimethyl-1-thia-4-azaspiro[4.4]nonane (4a): 8.96 min.
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The derivatization is conducted according t Reiner et al. [21]. 2,2,3-Trimethyl-1-thia-4-
azaspiro[4.4]nonane (4a) (54.1 mg, 0.29 mol) is dissolv d i diethylether (0.5 mL). Phenylisocya ate
(33.5 µL, 0.31 mmol) and cyclohexane (0.25 mL) re dded, the reaction mixture is st rred
over night, and the solvent is eva orated me nwhile. The solid is dried in vacuo, yielding
2,2,3-Trimethyl-N-phenyl-1-t a-4-azaspiro[4.4]nonan-4-carboxamide (5a) (82.3 mg, 0.27 mmol, 93%)
as white solid.
1H-NMR (500 MHz, CDCl3): δ (ppm) = 7.38–7.33 (m, 2 H, Ar-H), 7.32–7.27 (m, 2 H, Ar-H), 7.06–7.03
(m, 1 H, Ar-H), 3. 8 (q, J = 6.40 Hz, 1 H, C3-H), 3.03–2.96 (m, 1 H, (CH2)4), 2.86–2.79 (m, 1 H, (CH2)4),
2.18–2.09 (m, 1 H, (CH2)4), 1.97–1.83 (m, 4 , (CH2)4), 1.62–1.60 (m, 1 H, (CH2)4), 1.63 (s, 3 H, C2-CH3),
1.44 (d, J = 6.35 Hz, 3 H, C3-CH3), 1.32 (s, 3 H, C2-CH3).
13C-NMR (126 MHz, CDCl3): δ (ppm) = 152.4 (C=O), 138.9, 129.1, 123.4, 120.4 (Ar-C), 80.8 (C5 , 68.0
(C3), 51.9 (C2), 41.7, 41.1, 32.1, 23.7 ((CH2)4), 25.1 (C2-CH3), 25.1 (C2-CH3), 17.5 (C3-CH3).
HRMS (ESI) m/z calculated for C17H25N2OS [M + H]+: 305.16821, found: 305.1687.
2.5. HPLC Analytics for the Determination of the Enantiomeric Excess
F r a alysis of the enanti meric excess of 3-thiazolidine 4a, samples were derivatized according
to Section 2.4. The corresponding solids were dissolved in dichloromethane after deriv tization and
analyzed by means of a LC2000 SFC-HPLC system from Jasco (Easton, Los Angeles, CA, USA) with
HPLC column Chiralpak IC from Daicel (Tokyo, Japan) (supercritical CO2:EtOH (Et2NH) = 90:10
(0.01), 1 L·min−1, 20 ◦C, 10 MPa, 210 nm). Enantiomeric excess was determined based on area% of
the enantiomers.
In our previ us work, the absolute configuration of (S)-4a was determined by vibrational circular
dichroism (VCD) spectroscopy [17].
Retention times for enantiomers of 5a (derivatized 4a):(S)-5a:13.52 min, (R)-5a:17.57 min.
2.6. Biotransformation of 3-Thiazoline (3a) in the Presence of Different Amounts of Dimethyl Sulfoxide
(DMSO)/3-Chloro-3-methylbutan-2-one (1)/Cyclopentanone (2)
The biotransformations (10 mL) were performed starting from a 20 mM concentration of 2,2,3-
trimethyl-1-thia-4-azaspiro[4.4]non-3-ene (3a), 1 mg·mL−1 of lyophilized whole-cell catalyst (prepared
from 2 mg·mL−1 of cell suspension in 200 mM KPi buffer pH 7, construction of the whole-cell catalyst
is described in Section 2.2), 40 mM of D-glucose, 0.1 mM of NADP+, and 10% v/v of methanol or 20%
or 30% v/v of dimethyl sulfoxide (DMSO) as co-solvent in distilled water. Biotransformations in the
presence of 3-chloro-3-methylbutan-2-one (1) (5 or 20 mM) or cyclopentanone (2) (5 or 20 mM) were
performed at a co-solvent concentration of 20% v/v DMSO. The reactions were stirred at 30 ◦C for 18 h.
The reaction was stopped by adding 1 mL of 32% NaOH solution and 10 mL of dichloromethane. Phase
separation was promoted by centrifugation. The organic phase was dried over magnesium sulfate and
the conversion was determined by analyzing the organic phase by means of achiral GC (2.3).
2.7. Studies on Diffusion of 3a through the PDMS Membrane
For examination of the diffusion of 3a through the PDMS membrane, 3-thiazoline (3a) (345 mg,
1.87 mmol) was added to aqueous ammonia solution (5.6 M, 675 µL) inside the thimble. DMSO (10 mL)
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was added to the outer compartment and both solutions were stirred (inside the thimble stirring with
the mechanical stirrer, outside stirring was carried out using a stirring bar). After 0.75 h, 2 h, 3.5 h, 5 h,
and 6 h a sample of DMSO (100 µL) from the outer compartment was transferred to a GC vial, mixed
with dichloromethane (100 µL), and analyzed by means of achiral GC (2.3). After 6 h, the inner phase
(inside the timble) was extracted with dichloromethane (3 times). The combined organic phases were
dried over magnesium sulfate and the solvent was evaporated in vacuo. The remaining yellow oil
was dissolved in dichloromethane and analyzed by means of achiral GC (2.3). The concentration of
3-thiazoline (3a) in the outer compartment was calculated by means of a standard curve and related to
the maximum concentration of 3a in the outer compartment.
2.8. Synthesis of 3-Thiazoline (3a) via Asinger-Reaction in Different Reactor Types
Finely crushed sodium hydrosulfide monohydrate (333 mg, 4.49 mmol) was mixed with
cyclopentanone (2) (378 µL, 4.49 mmol) and aqueous ammonia-solution (675 µL, 13.3 M) inside
the thimble or a glass vial. 3-Chloro-3-methylbutan-2-one (1) (542 mg, 4.49 mmol) was added at
room temperature and the solution was stirred (stirring bar or mechanical stirrer) for 18 h at room
temperature. The reaction solution was extracted with dichloromethane (3 times), the combined organic
phases were dried over magnesium sulfate, and the solvent was evaporated in vacuo. The remaining
yellow oil was dissolved in dichloromethane and analyzed by means of achiral GC (2.3). The conversion
towards 3-thiazoline (3a) was calculated by means of a standard curve.
2.9. One-Pot Process Combining the Asinger-Synthesis of 3-Thiazoline (3a) with an Enzymatic Reduction via
Compartmentalization of the Reaction Steps
Finely crushed sodium hydrosulfide monohydrate (333 mg, 4.49 mmol) was mixed with
cyclopentanone (2) (378 µL, 4.49 mmol) and aqueous ammonia-solution (675 µL, 13.3 M) inside
the timble. 3-Chloro-3-methylbutan-2-one (1) (542 mg, 4.49 mmol) was added and the solution was
stirred (mechanical stirrer) for 18 h at room temperature. DMSO (10 mL) was added to the outer
compartment and both solutions were stirred (inside the thimble stirring with the mechanical stirrer,
outside stirring was carried out using a stirring bar) for 6 h. To the outer compartment, didestilled
water (7.8 mL), 200 mM D-glucose (6.7 mL of a 1.5 M stock solution), 0.1 mM NADP+ (0.5 mL of
10 mM stock solution), and 8 mg·mL−1 lyophilized whole-cell catalyst (prepared from 16 mg·mL−1
of cell suspension in 200 mM KPi buffer pH 7, construction of the whole-cell catalyst is described in
Section 2.2) were added. The outer reaction compartment is heated to 30 ◦C and both reaction solutions
(inner and outer compartment) were stirred for 24 h. The reaction was stopped by adding 2 mL of
32% NaOH solution and 50 mL of dichloromethane to the outer reaction solution. Phase separation
was promoted by centrifugation. The organic phase was dried over magnesium sulfate and the
conversion was determined by analyzing the organic phase by means of achiral GC (2.3). The organic
solvent was evaporated in vacuo and part of the product was derivatized according to Section 2.4 and
then analyzed by chiral SFC-HPLC (2.5). 2,2,3-Trimethyl-1-thia-4-azaspiro[4.4]nonane (4a) (100 mg,
0.54 mmol, 12%) was isolated by flash column chromatography using the Biotage “Isolera One“ flash
chromatography system (5–40% ethyl acetate in cyclohexane) as yellowish oil with an isolated yield of
12% and a purity of 97% (determined by 1H NMR spectroscopy).
1H-NMR (500 MHz, CDCl3): δ (ppm) = 3.10 (q, J = 6.60 Hz, 1 H, C3-H), 2.13–2.05 (m, 1 H, (CH2)4),
1.95–1.78 (m, 2 H, (CH2)4), 1.77–1.63 (m, 5 H, (CH2)4), 1.41 (s, 3 H, C2-CH3), 1.19 (s, 3 H, C2-CH3), 1.09
(d, J = 6.61 Hz, 3 H, C3-CH3).
13C-NMR (126 MHz, CDCl3): δ (ppm) = 81.5 (C5), 67.1 (C3), 59.9 (C2), 44.8, 42.4, 24.4, 23.9 ((CH2)4),
27.8 (C2-CH3), 26.1 (C2-CH3), 13.7 (C3-CH3).
The analytical data corresponds with literature data [17,21].
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3. Results and Discussion
3.1. Compartmentation Approach
In our recent study [17], synthesis of 3-thiazolidines (4) was performed via a two-pot-/two-
step-cascade (Figure 1A). The first step consists of an Asinger-type multi-component reaction as
an efficient synthesis of 3-thiazolines (3), which requires a basic pH around 12. The second step is
an enzymatic reduction of 3-thiazolines (3) catalyzed by imine reductases (IREDs), which proceeds
at a pH optimum of 7. Due to their different required pH conditions, the single reaction steps are
not compatible with each other. Therefore, we chose a compartmentalization approach to develop
a one-pot synthesis for the asymmetric synthesis of 3-thiazolidines (4). We used polydimethylsiloxane
(PDMS) thimbles, which in earlier works were shown to be permeable for hydrophobic and (mostly)
non-permeable for water-soluble components [10–14]. Thus, the use of PDMS thimbles was chosen for
compartmentalization of Asinger-type reaction and IRED-catalyzed reduction. Sodium hydrosulfide
and biocatalyst remain in their compartment, whereas 3-thiazoline (3) can pass the membrane after
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Figure 1. (A) Concept of our recent work: Synthesis of 3-thiazolidines (4a) in a two-pot-/two-step
cascade [17]. (B) Concept of this work: One-pot synthesis towards 3-thiazolidines (4a) via
compartmentalization approach using polydimethylsiloxane (PDMS) thimbles.
3.2. Studies on Asinger-Type Multi-Component Reaction
In order to design this one-pot process for the synthesis of 3-thiazolidines (4a), at first we studied
the initial reaction step of the cascade, namely the Asinger-type multi-component reaction. Since
the Asinger-type synthesis is conducted within a two-phase system of aqueous and organic phase,
the stirring rate and scale of the reaction turned out to have a tremendous effect on the conversion.
When the Asinger-type synthesis was performed in a flask on a 200 mmol scale with stepwise addition
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of the α-chlorinated ketone under cooling in the presence of dichloromethane (as a “benchmark
experiment”) [17], a conversion of 56% of 2,2,3-trimethyl-1-thia-4-aza-spiro[4.4]non-3-ene (3a) was
obtained (Figure 2A, control (flask, dropping funnel)). However, when the Asinger-synthesis was
performed on smaller scale (4.5 mmol) in a glass vial at room temperature (for comparison with the
subsequently described experiments with the PDMS thimble, which could not be cooled), allowing
a high stirring rate, conversion decreased to 41% after 18 h of reaction time at room temperature
(Figure 2A, control (glass vial)). Since the PDMS thimbles are sensitive to shearing forces, which
increase with higher stirring rates of the stirring bar inside the thimbles, the initial Asinger-type
reaction, being conducted inside the thimble at room temperature, was performed with a low stirring
rate using a stirring bar. In this case, only very low conversion of 3% for 3-thiazoline (3a) was obtained
after 18 hours of reaction time (Figure 2A, thimble (stirring bar)). As such a low conversion can
be directly linked to an unsufficient mixing due to a low stirring rate, we developed a mechanical
stirrer based on an overhead stirrer (KPG stirrer) to enable high rates and circumvent high shearing
forces at the same time (Figure 2B). The use of this mechanical stirrer increased the conversion in the
Asinger synthesis significantly to 25% after 18 h (Figure 2A, timble (mechanical stirrer)), representing
a promising starting point for an application in the cascade reaction towards the desired one-pot
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Figure 2. (A) Results for the Asinger-type multi-component reaction under different conditions.
(B) Mechanical stirrer based on a KPG stirrer for high stirring speed inside the PDMS thimble.
3.3. Diffusion Efficiency and Biocatalytic Reduction Using Imine Reductases
When performing a one-pot synthesis of 3-thiazolidine (4a) using PDMS thimbles for
compartmentalization, the diffusion rate of the 3-thiazoline (3a) is a critical point that needs to
be examined. The presence of an organic solvent turned out to be beneficial for the diffusion of
3a through the PDMS membrane according to the results of Uthoff et al. [14]. Therefore, we were
interested in using a water-miscible organic solvent being tolerated by the imine reductase to enhance
the diffusion of 3a. Methanol and dimethylsulfoxide (DMSO) represent such suitable co-solvents
for the biocatalytic reduction using a whole-cell catalyst. In order to obtain a high diffusion rate
of 2,2,3-trimethyl-1-thia-4-azaspiro[4.4]non-3-ene (3a), a high co-solvent concentration in the outer
aqueous compartment is desirable. We performed biotransformations of 3-thiazoline (3a) in the
presence of different amounts of methanol and DMSO at 30 ◦C for 18 h in order to examine the
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maximum amount of co-solvent that is tolerated by the Escherichia coli (E. coli) whole-cell catalyst.
In analogy to our previous work [17] an E. coli whole-cell catalyst was used, overexpressing the imine
reductase from Mycobacterium smegmatis [18] and a glucose dehydrogenase (GDH) from Bacillus subtilis
for in situ-cofactor recycling. The genes, encoding for IRED and GDH, have been inserted on different
plasmids. Unfortunately, the conversion of 3-thiazoline (3a) towards 4a is quite low, with only 25%
in the presence of 10% v/v methanol. Therefore, methanol does not represent a suitable co-solvent
that can be used in high concentrations which are required for the envisaged process. We found that
the reaction proceeds smoothly in the presence of 20% v/v DMSO giving 83% conversion after 18 h of
reaction time. In contrast, the conversion is dramatically decreased to 3% in the presence of 30% v/v
DMSO. Thus, as a compromise between high co-solvent concentration and high conversion, 20% v/v
DMSO was chosen for the cascade reaction (Figure 3).
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Figure 3. Results for the reduction of 3-thiazoline (3a) using a E. coli whole-cell catalyst in the presence
of different amounts of methanol/dimethylsulfoxide (DMSO) as a co-solvent.
With the optimal co-solvent concentration for the cascade reaction in hand, we examined the
diffusion of 3a through the PDMS membrane using an aqueous 20% v/v DMSO solution in the outer
compartment. Unfortunately, we found that the diffusion of 3a was slow with only 24% in the outer
media after 22 h. Therefore, we studied the diffusion using pure DMSO in the outer compartment and
observed that diffusion of 3a proceeds faster yielding 60% of 3a in the DMSO phase after 6 h.
Moreover, 3-chloro-3-methylbutan-2-one (1) and cyclopentanone (2), which are used as substrates
in the Asinger-type multi-component reaction (Figures 1 and 2), are able to pass the membrane (data
not shown). Therefore, we examined if the biocatalytic reduction is compatible with the α-chlorinated
ketone 1 and cyclopentanone (2). Thus, biotransformations of 3-thiazoline (3a) in the presence of
different concentrations (5 and 20 mM) of either cyclopentanone (2) or 3-chloro-3-methylbutan-2-one (1)
were conducted at 30 ◦C for 18 h. We were pleased to find that the IRED-catalyzed reduction proceeds
smoothly, even in the presence of 5 or 20 mM of 1 or 2, still giving 70% conversion in the presence of
Bioengineering 2018, 5, 60 8 of 10
20 mM cyclopentanone (2) and 60% conversion when the biotransformation was conducted in the
presence of 20 mM 3-chloro-3-methylbutan-2-one (1). This represents a slight decrease in conversion
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Figure 4. Results for the biotransformation of 3-thiazoline (3a) in the presence of different concentrations
of either cyclopentanone (2) or 3-chloro-3-methylbutan-2-one (1).
3.4. One-Pot Process Combining the Asinger-Synthesis of 3-Thiazoline (3a) with an Enzymatic Reduction via
Compartmentalization of the Reaction Steps
With the optimized single reaction steps for the synthesis of (S)-2,2,3-trimethyl-1-thia-4-
azaspiro[4.4]nonane (4a) in hand, we performed the envisaged one-pot process (Figure 5). The process
was carried out in a sequential fashion, since pure DMSO is required for a high diffusion
rate of 3-thiazoline (3a) through the PDMS membrane. Consequently, at first the Asinger-type
multi-component reaction is conducted inside the timble to synthesize 3a for 18 h at room temperature,
followed by diffusion of the 3-thiazoline (3a) for 6 h using pure DMSO in the outer compartment.
As the next step, buffer, NADP+, D-glucose, and lyophilized whole-cell catalyst are added to obtain
an aqueous solution for the biotransformation containing 20% v/v DMSO. After a reaction time of
24 h at 30 ◦C for the biotransformation, we found that 2,2,3-trimethyl-1-thia-4-azaspiro[4.4]nonane
(4a) was formed with an overall conversion of 13% and an excellent enantioselectivity of 99% ee
for the (S)-enantiomer. After work-up, the desired 3-thiazolidine(S)-4a was isolated in 12% yield
(Figure 5). Even though an overall conversion of 13% is relatively low, this overall conversion fits well
with the expected conversion being calculated from the single reaction steps. In the one-pot process,
we observed a quantitative conversion in the biotransformation step after extraction of the aqueous
phase with dichloromethane. Therefore, the biotransformation is not representing a limiting step in
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the one-pot process. Moreover, the expected conversion for the first two reaction steps, consisting of
Asinger-synthesis and diffusion of 3a through the PDMS membrane is 15% (taking into account 25%
for the Asinger-synthesis and 60% for the diffusion). Accordingly, the observed overall conversion of
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Figure  5.  One‐pot  process  towards  synthesis  of  (S)‐2,2,3‐trimethyl‐1‐thia‐4‐
azaspiro[4.4]nonane (4a). 
4. Conclusions 
We  reported  the  first  proof  of  concept  for  a  one‐pot  process merging  a  heterocycle 
formation through a classic chemical process at strongly basic conditions with a biocatalytic 
reaction under neutral pH conditions. For compartmentalization of the incompatible reaction 
step, PDMS  thimbles were used. This  one‐pot process was  applied  successfully  towards  a 
Figure 5. One-pot process towards synthesis of (S)-2,2,3-trimethyl-1-thia-4-azaspiro[4.4]nonane (4a).
4. Conclusions
We reported the first proof of concept for a one-pot process merging a heterocycle formation
through a classic chemical process at strongly basic conditions with a biocatalytic reaction under neutral
pH conditions. For compartmentalization of the incompatible reaction step, PDMS thimbles were used.
This on -pot process was appli d successfully towards a highly enantioselective synthesis of (S)-2,2,3-
trimethyl-1-thia-4-azaspiro[4.4]nonane utilizing commercially available and cheap starting materials.
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